Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lamontagne

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Canadian Family Physician Medecin De Famille Canadien|May 15, 2010
[Not Available]R Lamontagne
Revue D'Histoire Des Sciences|January 1, 1996
[The influence of Maurepas on the sciences: the botanist Jean Prat in New Orleans, 1735-1746]R Lamontagne
Continuum (Society for Social Work Administrators in Health Care)|February 8, 2000
Win/win partnership serves dementia populationR R Lamontagne
Continuum (Society for Social Work Administrators in Health Care)|April 2, 1999
Complementary care: expanding patients' optionsR R Lamontagne
Angiogenesis|January 10, 2006
Antiangiogenesis: new frontiers in therapeutic developmentKenneth R LaMontagne
The Journal of Infectious Diseases|September 1, 1980
From the National Institute of Allergy and Infectious Diseases: summary of a workshop on influenza B viruses and Reye's syndromeJ R LaMontagne
Commitment|December 8, 1977
Teamwork makes a difference in urban health centerD R LaMontagne
Journal of Virology|April 1, 1972
A bacteriophage of Bacillus subtilis which forms plaques only at temperatures above 50 C. II. Reduction of TSP-1-specific receptor sites on cells grown at 37 C or 45 C, and the temperature-dependent inactivation of replicating phageJ R LaMontagne, W C McDonald
Journal of Virology|April 1, 1972
A bacteriophage of bacillus subtilis which forms plaques only at temperatures above 50 C. 3. Inhibition of TSP-1-specific deoxyribonucleic acid synthesis at 37 C and 45 CJ R LaMontagne, W C McDonald
The Journal of Infectious Diseases|December 1, 1978
From the National Institutes of Health. Report of a workshop on clinical studies of the efficacy of amantadine and rimantadine against influenza vireusJ R LaMontagne, G J Galasso
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Canadian Family Physician Medecin De Famille Canadien|May 15, 2010
[Not Available]R Lamontagne
Revue D'Histoire Des Sciences|January 1, 1996
[The influence of Maurepas on the sciences: the botanist Jean Prat in New Orleans, 1735-1746]R Lamontagne
Continuum (Society for Social Work Administrators in Health Care)|February 8, 2000
Win/win partnership serves dementia populationR R Lamontagne
Continuum (Society for Social Work Administrators in Health Care)|April 2, 1999
Complementary care: expanding patients' optionsR R Lamontagne
Angiogenesis|January 10, 2006
Antiangiogenesis: new frontiers in therapeutic developmentKenneth R LaMontagne
The Journal of Infectious Diseases|September 1, 1980
From the National Institute of Allergy and Infectious Diseases: summary of a workshop on influenza B viruses and Reye's syndromeJ R LaMontagne
Commitment|December 8, 1977
Teamwork makes a difference in urban health centerD R LaMontagne
Journal of Virology|April 1, 1972
A bacteriophage of Bacillus subtilis which forms plaques only at temperatures above 50 C. II. Reduction of TSP-1-specific receptor sites on cells grown at 37 C or 45 C, and the temperature-dependent inactivation of replicating phageJ R LaMontagne, W C McDonald
Journal of Virology|April 1, 1972
A bacteriophage of bacillus subtilis which forms plaques only at temperatures above 50 C. 3. Inhibition of TSP-1-specific deoxyribonucleic acid synthesis at 37 C and 45 CJ R LaMontagne, W C McDonald
The Journal of Infectious Diseases|December 1, 1978
From the National Institutes of Health. Report of a workshop on clinical studies of the efficacy of amantadine and rimantadine against influenza vireusJ R LaMontagne, G J Galasso
Pageof 5